Policy Paper: Exploring perceptions of bacteriophage use in the UK across the One Health spectrum: a roundtable discussion
In 2022, AMI won the UK Government My Science Inquiry and recommended bacteriophages as alternatives to antimicrobials to counter the threat of antimicrobial resistance. In July 2024, AMI held a closed roundtable discussion, inviting bacteriophage experts across the One Health spectrum and all stages of the phage development pipeline to discuss some of the major barriers to phage therapy implementation within the UK. Overall, the lack of investment, national infrastructure and public awareness regarding phage therapy, its development and its potential, were agreed upon as the key barriers that need to be overcome to more widely implement phage therapy across the UK. This paper seeks to provide a next step for phage therapy, continuing momentum to facilitate its widespread implementation.
Find the publication here and executive summary below.
